Monthly Archives: November 2017
Hydrogel based localized drug delivery has major advantages over the conventional systemic and oral drug delivery in terms of maintaining therapeutic concentration of the drugs at the target site and minimal concentration in rest of the major organs of the body, sparing them of the undesired side effects and toxicity. Doxorubicin (DOX) and Docetaxel (DTX) […]Read more
Tamoxifen-Phospholipid Conjugate: A Promising Anticancer Therapeutic with Improved Antitumor Activity and Reduced Liver Toxicity.
Gynecological cancers such as breast cancer is rapidly rising in India. Surgical resection of breast tumors is the main form of therapy. To reduce the recurrence of tumors in breast cancer patients, Tamoxifen (anticancer drug) is administered daily as oral tablets up to 1-2 years. Acidic pH of stomach precipitates the Tamoxifen, thereby requiring frequent […]Read more
Dr. Avinash Bajaj’s lab is primarily focused in the development and finding of new drug delivery molecules and bio-inspired materials for the betterment of conventional chemotherapeutic strategies. Over the years his group exploited bile acids in developing cancer targeting cationic lipids, bile acid based drug conjugates, and further designed bile acid-phosphocholine- derived phospholipids for drug […]Read more